Maximum-tolerated dose, toxicity, and efficacy of 131I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma

Gerald L Denardo, Sally J. DeNardo, Desiree S. Goldstein, Linda A. Kroger, Kathleen R. Lamborn, Norman B. Levy, John P McGahan, Qansy Salako, Sui Shen, Jerry P. Lewis

Research output: Contribution to journal › Article › peer-review

194 Scopus citations

Fingerprint

Dive into the research topics of 'Maximum-tolerated dose, toxicity, and efficacy of 131I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences